REALIZE - Trial of a new treatment for drug-resistant focal epilepsy

Focal Epilepsy

The REALIZE study is a placebo-controlled clinical trial designed to test the effectiveness, safety and tolerability of investigational drug CVL-865, given as an oral pill, as a treatment for drug-resistant focal onset epilepsy.  Participants will be randomly assigned to receive either CVL-865 or placebo, in addition to the medications they are already taking.  The study aims to determine whether CVL-865 is effective in reducing seizure frequency compared to participants receiving placebo.

Participants who complete the study have the option to join an “open-label” extension study, in which all participants receive the investigational drug.

Trial Status
Trial Phase
Phase 2 Drug Trial
Trial contact details
Contact Person
Delphine Lévy-Bencheton
What you need to know

Who can take part?

  • Males and females aged 18 to 75 years, who have been diagnosed with focal onset, focal aware, focal impaired awareness, and focal to bilateral tonic-clonic seizures for at least 2 years
  • People with 4 or more seizures per month
  • People who have failed to achieve seizure control with at least 2 prior antiepileptic drugs
  • People taking certain medications may be ineligible to participate – discuss with the study team
  • Participants of childbearing potential must avoid pregnancy during the study

What is involved for you?

  • CVL-865 or placebo taken as an oral pill, twice a day
  • MRI or CT scan
  • Keep a seizure diary
  • Questionnaires
  • Physical exams and vital signs
  • Neurological exams
  • Electrocardiogram
  • Blood tests
  • Urine tests

Trial dates

This trial is accepting participants until April 2023.

All research clinical trials news

Mater researchers in Brisbane are leading a trial of a game-changing flu vaccine that has the potential to provide greater and more durable protection against the virus.



Mater launches trial of Australian-first flu vaccine

Stephanie Guilas has worked in many departments throughout Mater Hospital Brisbane, however, after 28 years of service, she found her true passion working within Mater Research’s Mothers and Babies...



Stephanie Guilas is improving outcomes for mums and bubs through research

Working as a research assistant in an immunology research lab, Yvonne Gautam learnt what a clinical trial was after being asked to set up a lab for a Phase Two clinical trial.



Clinical Trials Coordinator Yvonne Gautam is working towards creating better treatments for patients with diabetes

Displaying results 1-3 (of 16)
 |<  < 1 - 2 - 3 - 4 - 5 - 6  >  >|